These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Control of heparin therapy. Sensitivity of the activated partial thromboplastin time for monitoring the antithrombotic effects of heparin. Zucker S; Cathey MH J Lab Clin Med; 1969 Feb; 73(2):320-6. PubMed ID: 5764028 [No Abstract] [Full Text] [Related]
6. [Laboratory controls of heparin therapy with thrombin time, partial thromboplastin time and activated recalcification time]. Lutze G; Presser HJ; Urbahn H Z Gesamte Inn Med; 1989 Apr; 44(8):235-40. PubMed ID: 2662657 [TBL] [Abstract][Full Text] [Related]
7. Heparin assay methods for control of in vivo heparin effects. Godal HC Thromb Diath Haemorrh; 1975 Feb; 33(1):77-80. PubMed ID: 1091021 [No Abstract] [Full Text] [Related]
8. [Monitoring heparin therapy by thrombin time and activated partial thromboplastin time--a comparison]. Lang M; Fey MF; Furlan M; Beck EA Schweiz Med Wochenschr; 1986 Nov; 116(48):1681-4. PubMed ID: 3798064 [TBL] [Abstract][Full Text] [Related]
10. Comparison of activated recalcification and partial thromboplastin tests as controls of heparin therapy. Ray PK; Harper TA J Lab Clin Med; 1971 Jun; 77(6):901-7. PubMed ID: 5559859 [No Abstract] [Full Text] [Related]
11. The activated coagulation time test as a control for heparin therapy. Cho P; Bonilla-Linero F; Yim E Hawaii Med J; 1971; 30(6):474-7. PubMed ID: 5156964 [No Abstract] [Full Text] [Related]
12. Control and complications of intermittent heparin therapy. Norman CS; Provan JL Surg Gynecol Obstet; 1977 Sep; 145(3):338-42. PubMed ID: 888052 [TBL] [Abstract][Full Text] [Related]
13. [Laboratory control of anticoagulant treatments (author's transl)]. Samama M; Conard J; Horellou MH J Mal Vasc; 1981; 6(4):257-61. PubMed ID: 7320641 [TBL] [Abstract][Full Text] [Related]
14. Activated partial thromboplastin time test in heparin therapy. A study. Simmons A; Cross DE Mo Med; 1969 Jun; 66(6):430-3. PubMed ID: 5771362 [No Abstract] [Full Text] [Related]
16. On the value of the activated partial thrombo-plastin time (aptt) in monitoring heparin therapy. Teien AN; Abildgaard U Thromb Haemost; 1976 Jun; 35(3):592-7. PubMed ID: 989966 [TBL] [Abstract][Full Text] [Related]
17. The activated partial thromboplastin time as a monitor of heparin therapy: a warning. Makary AZ; Waterbury L Johns Hopkins Med J; 1977 Jun; 140(6):311-5. PubMed ID: 864903 [TBL] [Abstract][Full Text] [Related]
18. [Heparin therapy and its monitoring]. Camici M; Evangelisti L Clin Ter; 1991 Feb; 136(4):279-82. PubMed ID: 1827391 [No Abstract] [Full Text] [Related]
19. [Effect of various laboratory tests in the control of anticoagulant therapy]. Molinas FC; Sanchez Avalos JC Medicina (B Aires); 1967; 27(2):107-15. PubMed ID: 5600645 [No Abstract] [Full Text] [Related]
20. [Monitoring of heparin therapy with activated recalcification time]. Lutze G; Schlote A; Urbahn H Z Gesamte Inn Med; 1981 Feb; 36(4):102-6. PubMed ID: 7222858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]